Senior Vice President
Wed, Apr 20, 2022
Apr 20
exercised or converted securities in APLS
7,000 shares @ $15.52
Increased holdings by +24.60%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology